Repository logo
  • English
  • 中文
  • Log In
    New user? Click here to register.Have you forgotten your password?
Repository logo
    Communities & Collections
    Research Outputs
    Fundings & Projects
    People
    Organizations
    Statistics
  • English
  • 中文
  • Log In
    New user? Click here to register.Have you forgotten your password?
  1. Home
  2. TMU Publications / 北醫出版品
  3. 北醫學報
  4. 第23卷, 第1期
  5. 雜環醌類之生理活性III:吲哚喹啉酮之合成
 
  • Details
Options

雜環醌類之生理活性III:吲哚喹啉酮之合成

Other Title
Heteroquinones with Biological Activity III-Synthesis of Indoloquinolinequinones
Type
journal article
Date Issued
1994
Author(s)
HSIEN-SHOU KUO
CHUNG-LUNG WANG
郭憲壽
王宗隆
Subjects
北醫出版品
北醫學報
URI
https://203.71.86.71/handle/123456789/47977
File(s)
No Thumbnail Available
Name

Heteroquinones with Biological Activity III-Synthesis of Indoloquinolinequinones.pdf

Size

4.38 MB

Format

Adobe PDF

Checksum

(MD5):2198e5ac7b2ddccd45eeb329e8c4fb17

Copyright Notice

● The digital content on this platform is part of the Taipei Medical University Institutional Repository, featuring various academic works and outputs from the institution. It offers free access to academic research and public education for non-commercial use.

● Please use the content appropriately and within legal boundaries to respect copyright owners' rights. For commercial use, please obtain prior authorization from the copyright owner. Users must not use TMUIR for any illegal purposes.

● By utilising the platform, users are deemed to have fully accepted and understood all the regulations set out in this statement, relevant laws of the Republic of China, all international internet regulations, and usage conventions.

● TMUIR is committed to protecting the interests of copyright owners. If you believe that any material on this website infringes copyright, please contact our staff at libirtmu@gmail.com, and we will remove the work from the repository.

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science

  • Cookie settings
  • Privacy policy
  • End User Agreement
  • Send Feedback